Online Read Free Novel
  • Home
  • Romance & Love
  • Fantasy
  • Science Fiction
  • Mystery & Detective
  • Thrillers & Crime
  • Actions & Adventure
  • History & Fiction
  • Horror
  • Western
  • Humor

    How to Change Your Mind

    Page 48
    Prev Next


      and rewiring of brain, 317, 318–19

      Schuster on research potential of, 51

      and second wave of research, 79, 333

      and Spring Grove’s research, 218

      and Stamets’s messenger theory, 124–25

      and studies requested by FDA, 375–76

      synthetic version of, 83–84, 113

      as tryptamine, 291–92

      See also mushrooms

      “Psilocybin Can Occasion Mystical-Type Experiences Having Substantial and Sustained Personal Meaning and Spiritual Significance” (Griffiths, Richards, McCann, Jesse), 10–11, 29–30

      Psilocybin Mushrooms of the World (Stamets), 86

      Psychedelic Drugs Reconsidered (Grinspoon and Bakalar), 194

      The Psychedelic Explorer’s Guide (Fadiman), 229

      psychedelic journeys of Pollan

      and cardiac concerns, 235–37, 244–45, 245n

      and language of mysticism, 285–87

      with LSD, 237–54

      and mystical experience survey, 282–84

      with psilocybin, 254–72, 284

      recaps and reflections on, 250–54, 269–72, 281–84

      and search for a guide, 231–35

      as “spiritual” experience, 288–90

      with The Toad (5-MeO-DMT), 272–90

      Psychedelic Psychiatry (Dyck), 146n

      Psychedelic Science 2017, 397

      psychedelic therapy

      as “applied mysticism,” 207

      and aspirations of proponents, 173

      and betterment of well people, 45, 51, 78, 401, 404

      and California Institute of Integral Studies, 233

      and Cohen’s ambivalence about LSD, 158–59

      criticisms and challenges faced by, 207–8

      and ego dissolution, 389–90

      emergence of paradigm, 160, 163–64, 169–71, 207

      and established psychiatric field, 207

      at frontier of spirituality and science, 334

      future of, 400–405

      growing recognition of, 399

      and Hubbard, 160, 164, 169–70, 171, 207

      key role of experience in, 149, 169

      and low risks, 210

      and previous theoretical models, 207

      and priming patients, 169–70

      protocols and agreements of, 215, 226–27

      and “psychedelic-assisted therapy” term, 365, 399

      range of disorders addressed by, 382–83

      as reboot of system, 366, 384, 389

      results of, 368–69

      and return of symptoms, 380–81

      revival of, 369

      role of environment in, 163–64, 169–70, 207–8, 365

      role of therapist in, 365–66, 368 (see also guides)

      shamanism’s role in, 334

      spiritual trappings of, 207

      and suggestibility of psychedelics, 158–59, 170

      visual imagery in, 365–66

      See also addiction; cancer patient research; depression

      “psychedelics” term, 18–19, 144–45, 160, 162–63

      psychiatry field, 207–8, 211, 400

      psychoanalysis, 149, 155, 207, 296–97, 311

      psycholytic model, 154–57, 207

      psychosis

      and entropic brain theory, 313, 385

      panic reactions mistaken for, 210

      psychotic breaks, 3, 14, 209, 211

      and psychotomimetic model, 145, 150–51, 154, 162

      and risks associated with psychedelics, 14, 233

      psychotherapy, 2–3, 186, 351, 369, 406

      psychotomimetic model, 145–50

      and CIA’s psychedelic research, 172

      and Cohen, 153–54

      and established psychiatric field, 207

      and Osmond, 162, 169

      and psychiatrists’ criticisms of psychedelic therapy, 208

      and Saskatchewan Mental Hospital in Canada, 147–50

      quantum mechanics, 413–14

      Raichle, Marcus, 301, 303

      Ram Dass, 203, 205, 360. See also Alpert, Richard

      Rank, Otto, 155

      rat park experiment, 372–73

      Realms of the Human Unconscious (Grof), 297

      recidivism at Concord State Prison experiment, 46, 190–91, 190n, 195

      “recreational” drug use, 38, 228, 399, 400

      religion

      and drug use in religious practices, 27–28

      fanaticism/fundamentalism in, 81

      origins of religious belief, 55–56, 85, 106, 111–12

      and suppression of psychoactive plants, 2, 109

      See also spirituality

      Religious Freedom Restoration Act of 1993, 27

      renaissance of psychedelics

      and Griffiths’s landmark paper, 11, 29–30

      and Hofmann’s 100th birthday celebration/symposium, 21–22, 26–27

      and second wave of research, 3–4

      and UDV court case, 27–28

      research on psychedelics, first wave, 138–218

      and aspirations of proponents, 173, 212–13

      bad trips in, 152

      challenges faced by, 144

      congressional hearings on, 217

      and counterculture, 215

      end of, 59–60, 216–17

      and expectancy effects, 143–44

      and exuberance of researchers, 144, 212–13

      federal monitoring of, 166

      federal restrictions on, 197

      federal support for, 57–58

      funding for, 57

      Good Friday (Marsh Chapel) Experiment, 45–46, 60, 80–81, 191–92

      and guides, 200

      hubs of research, 153

      initiated by Sandoz’s Delysid distribution, 143

      and International Foundation for Advanced Study, 43–44, 177–80, 198, 217, 228

      Jesse’s interest in, 44–46

      Leary’s impact on, 9, 185–86, 190, 198–99, 212, 219–20

      and LSD therapy for alcoholism, 148–52

      and methodological issues, 152, 208

      and moral panic provoked by psychedelics, 185, 205

      and psychedelics’ escape from the lab, 157–58, 197

      and psycholytic model, 154–57

      and psychotomimetic model, 145–50

      researchers’ consumption of drugs, 146, 148, 189, 195, 208

      reunion of figures in (1979), 218–20

      at Saskatchewan Mental Hospital in Canada, 147–50

      skepticism toward, 144

      at Spring Grove facilities, 52, 56–58, 59, 218

      structured approaches/protocols of, 214–15

      suppression of, 44, 57–58, 60, 141–42, 332

      and terminal patients, 338–40

      volume and scope of, 44–45, 141–42

      See also Central Intelligence Agency (CIA); Harvard Psilocybin Project

      research on psychedelics, second wave

      absence of adverse events in, 14–15

      and betterment of well people, 45, 51, 78, 401, 404

      challenges faced by, 333–34

      and counterculture of the sixties, 84

      critics of, 76

      and CSP website, 43

      and discoveries of first-wave research, 332

      and exuberance of researchers, 26–27, 381, 382

      FDA protocols on, 48

      federal sanctioning of, 48

      and Hofmann’s 100th birthday celebration/symposium, 21–22, 26–27

      Jesse’s role in, 34–35

      and methodological issues, 333–34

      and phase 3 trials for psychedelics, 397, 400

      replication of
    Good Friday experiment, 192

      role of scientific outsiders in, 34–35

      with synthetic psilocybin, 83–84

      and underground therapists, 227

      See also cancer patient research

      Rheingold, Howard, 183

      Richards, Bill

      on authenticity questions, 347

      as bridge between first/second eras, 52–53

      flight instructions prepared by, 63, 72

      and Jesse, 52, 53

      and Pahnke, 53, 54–55

      and psilocybin trials at Hopkins, 60–61

      psychedelic experiences of, 53–55

      at Spring Grove, 52, 56–58, 218

      and terminal patients, 339

      risky behaviors of people on psychedelics, 14

      rite of passage, psychedelic trips as, 3, 216, 246

      rituals for psychedelics, 404

      Roberts, John G., 27

      Roman Catholic Church, 2, 109

      Romantic scientists, 126–28

      Ross, Stephen

      on alcoholism, 369–70

      and new respectability of research, 350

      on results with cancer patients, 336

      and studies requested by FDA, 375–76

      on suppression of research, 141–42, 332

      rotating face mask test, 261–63, 267, 308

      Rouiller, Ian, 379

      rumination, 313, 329, 353, 377–78, 383

      Russell, Bertrand, 355

      Russula mushroom, 119

      Sabina, María

      in Pollan’s psychedelic journeys, 261, 317

      and Wasson, 110, 112, 113–14, 114n

      sacraments, psychedelic used as, 2, 27–28, 83, 93, 107–9, 112

      Sahagún, Bernardino de, 108

      Samorini, Giorgio, 123–24

      Sandoz pharmaceutical firm

      creation of LSD-25, 1–2, 22–23

      distribution of LSD-25 (Delysid), 142–43, 148, 152, 176

      and Hubbard, 167, 170

      and psychotomimetic model, 145–46

      withdrawal of Delysid, 143, 216–17

      Saskatchewan Mental Hospital in Canada, 147–50. See also Hoffer, Abram; Osmond, Humphry

      Savage, Charles, 177

      schizophrenia

      and emergence of neurochemistry field, 146–47

      and LSD as trigger of psychotic breaks, 209–10

      and psychotomimetic model, 145–46, 162

      and rotating face mask test, 262

      and Spring Grove’s research, 218

      Schultes, Richard Evans, 107

      Schuster, Charles “Bob,” 30, 34, 49–50

      Schwartz, Peter, 181–82, 183

      science

      and Cohen’s ambivalence about LSD, 158–59

      as a means to mystical experience, 77–78, 81

      methodological standards in, 208

      and mysticism-science paradox, 347–48

      and nature’s mysteries, 12

      and Romantic scientists, 126–28

      and spirituality, 30–31, 73–74, 80, 174–75, 207, 334

      and testimony of individuals, 42

      and validation of mystical experiences, 347–48

      The Secret Chief (Zeff), 225

      senses and perceptions, 308–9

      sensory deprivation, 306

      serotonin, 24, 147, 292, 314n

      set and setting, 14, 53, 151, 190, 207–8

      shamanism, 84, 170, 214–15, 334, 348

      ’shrooms (term), 92

      Shulgin, Ann, 44, 102

      Shulgin, Sasha, 44, 102, 236, 237

      side effects of psychedelics, 210

      Silicon Valley, 44, 175–83

      Skinner, B. F., 149

      Slater, Toby, 330

      Smith, Huston

      and Council on Spiritual Practices, 49

      and Good Friday (Marsh Chapel) Experiment, 45

      on Griffiths’s landmark paper, 80–81

      and Jesse, 44, 49

      on spirituality, 136, 402

      Smith, Robert Ellis, 196

      smoking cessation, 78, 360–64

      Smythies, John, 146

      social media, 304

      Sokel, Karin, 71

      Solomon, Andrew, 383

      Spanish suppression of psychoactive mushrooms, 59–60, 108

      spirituality

      and ego dissolution, 390

      and Griffiths’s landmark paper, 10–11, 29–30

      and modern medicine, 334

      and Pollan’s psychedelic journeys, 288–90

      and role of guides, 402

      and science, 30–31, 73–74, 80, 174–75, 207, 334

      state of, 136

      sports, 306

      Spring Grove hospital and research center, 52, 56–58, 59, 218

      Stace, W. T., 282

      Stamets, Paul

      advocacy for fungi, 87–90

      background of, 87, 98–100

      on evolutionary function of psilocybin, 121

      expertise in mycology, 86, 99, 127

      field guides of, 86, 92

      Fungi Perfecti operation of, 86n, 126

      and Hofmann, 97, 103

      home of, 96–97

      honors accorded to, 91–92

      on human evolution, 115–16

      hunting for mushrooms, 117–21

      and images of Psilocybes, 115

      and McKenna, 116

      and mushroom conferences, 102–3

      on mushroom identification, 94–95

      mushroom stone artifacts of, 114–15

      Mycelium Running, 88, 90

      mycological theories of, 124–26, 136

      new species identified by, 86

      and P. azurescens, 86, 92, 118, 120–21, 129

      Psilocybe Mushrooms and Their Allies, 101

      Psilocybin Mushrooms of the World, 86

      as Romantic scientist, 126–28

      and ’shrooms (term), 92

      and Stoned Ape Theory, 97–98, 115–17

      Stanford Research Institute (SRI), 180–82

      Stanford University, 44, 180

      Stanley, Owsley, III, 181n

      Steindl-Rast, David, 49

      stigmas of psychedelic drugs, 104

      Stolaroff, Myron

      background of, 175–76

      career pivot of, 44, 177, 206n

      and guides, 230

      and Hubbard, 168, 177

      and International Foundation for Advanced Study (IFAS), 177

      and Jesse, 44, 46

      and Leary, 198, 199, 200–201

      psychedelic experiences of, 176

      and psychedelics in Silicon Valley, 176–77

      and reunion of first wave figures, 219

      and underground therapists, 227

      and Zeff, 225, 227

      Stoned Ape Theory, 97–98, 115–17

      Strassman, Rick, 48

      subconscious, 155

      subjectivity, 305–6, 413

      suggestibility of psychedelics

      and attributions of meaning, 354

      and Cohen’s ambivalence about LSD, 158

      and expectations of users, 25

      and Hopkins’s psilocybin research, 64

      and Hubbard, 170

      and placebo effect, 347

      suicides, 3, 210, 211, 335, 388

      Summergrad, Paul, 398, 401, 403

      synesthesia, 115–16, 145, 317

      talking therapy, 155

      technological advances, 183–84

      Tennyson, Alfred, Lord, 287

      teonanácatl (sacred mushroom of the Aztecs), 2, 107

      terminal patients, 78–79, 338–40. See also cancer patie
    nt research

      thalidomide tragedy, 197, 208

      time travel, mental faculty of, 387

      Time-Life publications, 104

      Toad. See 5-MeO-DMT (the Toad)

      tolerance for psychedelics, 14, 299

      “Tomorrow Never Knows” (Beatles), 143

      toxicity of psychedelics, low levels of, 50

      trances, 242–44

      transiency of mystical experiences, 71–72

      travel metaphors for psychedelic experiences, 15

      trees and mycelial networks, 91, 91n, 118

      trepanation, 298

      True: The Man’s Magazine, 113

      truths, revelations of, 70, 251, 305–6

      tryptamines, 291–92

      Turner, Brian, 65–66, 73–74

      UDV court case, 27–28, 43, 49

      University of California, Los Angeles, 8, 37, 152–53

      University of New Mexico, 369

      U.S. Food and Drug Administration (FDA)

      and approval of Strassman’s trial, 48

      depression studies requested by, 375–76

      and Hubbard’s clinical research, 167

      and phase 3 trials approvals, 397

      and potential rescheduling of psychedelics, 36, 397

      and psilocybin trials at Hopkins, 60

      regulation of experimental drugs, 146, 197

      research approvals revoked by, 217–18

      and thalidomide tragedy, 197

      U.S. Supreme Court, 27–28

      The Varieties of Religious Experience (James), 69

      Vietnam War, 139, 206, 215–16

      virtual reality, 183

      visualizing thoughts, 365–66

      Vogt, Walter, 22

      Vollenweider, Franz, 293, 301, 320, 334, 384

      Wallace, David Foster, 388

      Wasson, R. Gordon

      critics of, 112

      field notebooks of, 110–11

      and Hubbard, 170

      Life magazine article of, 2, 103–9, 113

      and mushroom conferences, 103

      Mushrooms, Russia, and History, 114n

      and mushrooms from southern Mexico, 2, 59, 101, 110–14, 114n

      and origins of religious belief, 106, 111–12

      preconceived theories of, 112

      psychedelic experiences of, 110–12

      Watts, Rosalind, 377, 379, 380, 381

      Weathermen, 204

      Weil, Andrew

      on active placebos, 159

      and dismissals of Leary and Alpert, 201–3

      and mushroom conferences, 102

      The Natural Mind, 159

      and Schultes, 107

      and Toad (5-MeO-DMT), 274

      and treatment of bad trips, 210

      well-being, improvements in, 74, 254, 285

      Whitman, Walt, 194, 286

      Whole Earth Network, 182, 183

      Wilson, Bill, 141, 152–53, 369

      Wilson, E. O., 80

     


    Prev Next
Online Read Free Novel Copyright 2016 - 2026